Pete A. Meyers
CIK 1590862 · Chief Financial Officer · last filed 2020-01-27
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
12
Lifetime Open-Market Net
$1.09M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| EAGLE PHARMACEUTICALS, INC. (EGRX) Delisted | Chief Financial Officer | 43,615 | $2.14 | $93.3K | $44.4K | 7 | 2020-01-27 |
| TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted | CFO & Treasurer | 153,891 | — | — | $1.05M | 5 | 2015-03-31 |
Recent Filings · Page 2 of 2
12 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-11-13 | TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted | Buy (P) | +5,000 | $19.9K | EDGAR |
| 2013-12-19 | TETRALOGIC PHARMACEUTICALS CORP (TLOG) Delisted | Mixed | +142,857 | $1000.0K | EDGAR |
Showing 11–12 of 12
Prev
Page 2 of 2
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.